Skip to main content
Journal cover image

Glucagon receptor as a drug target: A witches' brew of eye of newt (peptides) and toe of frog (receptors).

Publication ,  Journal Article
Nunez, DJ; D'Alessio, D
Published in: Diabetes Obes Metab
February 2018

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Diabetes Obes Metab

DOI

EISSN

1463-1326

Publication Date

February 2018

Volume

20

Issue

2

Start / End Page

233 / 237

Location

England

Related Subject Headings

  • Signal Transduction
  • Receptors, Glucagon
  • Molecular Targeted Therapy
  • Hypoglycemic Agents
  • Humans
  • Glucagon-Like Peptide-1 Receptor
  • Endocrinology & Metabolism
  • Drugs, Investigational
  • Diabetes Mellitus, Type 2
  • Antibodies, Monoclonal, Humanized
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Nunez, D. J., & D’Alessio, D. (2018). Glucagon receptor as a drug target: A witches' brew of eye of newt (peptides) and toe of frog (receptors). Diabetes Obes Metab, 20(2), 233–237. https://doi.org/10.1111/dom.13102
Nunez, Derek J., and David D’Alessio. “Glucagon receptor as a drug target: A witches' brew of eye of newt (peptides) and toe of frog (receptors).Diabetes Obes Metab 20, no. 2 (February 2018): 233–37. https://doi.org/10.1111/dom.13102.
Nunez, Derek J., and David D’Alessio. “Glucagon receptor as a drug target: A witches' brew of eye of newt (peptides) and toe of frog (receptors).Diabetes Obes Metab, vol. 20, no. 2, Feb. 2018, pp. 233–37. Pubmed, doi:10.1111/dom.13102.
Nunez DJ, D’Alessio D. Glucagon receptor as a drug target: A witches' brew of eye of newt (peptides) and toe of frog (receptors). Diabetes Obes Metab. 2018 Feb;20(2):233–237.
Journal cover image

Published In

Diabetes Obes Metab

DOI

EISSN

1463-1326

Publication Date

February 2018

Volume

20

Issue

2

Start / End Page

233 / 237

Location

England

Related Subject Headings

  • Signal Transduction
  • Receptors, Glucagon
  • Molecular Targeted Therapy
  • Hypoglycemic Agents
  • Humans
  • Glucagon-Like Peptide-1 Receptor
  • Endocrinology & Metabolism
  • Drugs, Investigational
  • Diabetes Mellitus, Type 2
  • Antibodies, Monoclonal, Humanized